Colinz Laboratories Limited (BOM:531210)
47.85
+1.56 (3.37%)
At close: Apr 10, 2026
Colinz Laboratories Market Cap
Colinz Laboratories has a market cap or net worth of 120.54 million as of April 10, 2026. Its market cap has decreased by -27.73% in one year.
Market Cap
120.54M
Enterprise Value
52.94M
Revenue
58.40M
Ranking
n/a
PE Ratio
24.41
Stock Price
47.85
Market Cap Chart
Since May 26, 2005, Colinz Laboratories's market cap has increased from 39.08M to 120.54M, an increase of 208.43%. That is a compound annual growth rate of 5.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 120.54M | -10.78% |
| Dec 31, 2025 | 135.10M | -23.12% |
| Dec 31, 2024 | 175.73M | 74.40% |
| Dec 29, 2023 | 100.76M | -48.73% |
| Dec 30, 2022 | 196.55M | 55.52% |
| Dec 31, 2021 | 126.39M | 93.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hamps Bio | 191.66M |
| Zenith Healthcare | 176.80M |
| Norris Medicines | 142.21M |
| Desh Rakshak Aushdhalaya | 139.89M |
| Beryl Drugs | 129.48M |
| Emmessar Biotech & Nutrition | 123.50M |
| Shamrock Industrial Company | 115.99M |
| Ortin Global | 106.20M |